Visiopharm’s Qualitopix advances standardisation of tissue biomarker staining with Ocus scanners

divider

Grundium’s Ocus® scanners and Visiopharm’s AI-driven Qualitopix are a great match for measuring and documenting your tissue staining consistency.

July 25, 2024

Grundium's Ocus® scanners were Visiopharm's choice for their Qualitopix solution, which is developed to advance precision pathology through standardization of tissue biomarker staining.

With concerningly high error rates of IHC staining in laboratories (10-30%), the Qualitopix® solution enables continuous measuring, monitoring, and documentation of staining consistency, promptly identifying, and addressing any deviations.

Visiopharm is partnering with Grundium, as the Ocus® scanners are affordable, fast and easy to setup, and require no additional hardware or software. Qualitopix and Ocus® scanners provide a simple workflow that allows you to easily scan and upload your slides to Qualitopix for analysis, enabling laboratories to trust their staining through AI-driven quantification and monitoring.

 

Learn more about Qualitopix

Qualitopix logo

About Grundium

Grundium is a global leader in digital imaging for pathology, transforming how medical professionals diagnose and treat diseases. Founded in 2015 and based in Tampere, Finland, the company leverages over two decades of expertise in optics and imaging to develop the Ocus® digital microscope slide scanners. These compact, high-precision devices make high-quality digital and remote pathology accessible to all, offering ease of use and affordability for labs of any size.

Trusted by healthcare providers worldwide, Grundium’s solutions enhance diagnostic accuracy, streamline workflows, and reduce unnecessary logistical steps—ultimately driving better patient outcomes through innovative technology.